Literature DB >> 8992870

Hypertrophic cardiomyopathy in Noonan syndrome.

T Nishikawa1, S Ishiyama, T Shimojo, K Takeda, T Kasajima, K Momma.   

Abstract

Noonan syndrome, a well-known multiple congenital anomalies syndrome, is frequently accompanied by cardiovascular diseases including hypertrophic cardiomyopathy (HCM). The incidence of HCM in Noonan syndrome is approximately 20-30% and one-third of cases reveal ventricular outflow obstruction. HCM in Noonan syndrome is occasionally associated with a congenital heart defect, whereas classic HCM seldom accompanies cardiac malformations. Asymmetric septal hypertrophy and symmetric septal hypertrophy (concentric hypertrophy) can be observed both in HCM with Noonan syndrome and in classic HCM, but apical hypertrophy has not been reported in Noonan syndrome yet, although it appears in classic HCM. Congestive heart failure is the major cause of death in patients with HCM in Noonan syndrome, but cases of sudden death have also been reported. The histopathologic findings of ventricular myocardial tissue in HCM with Noonan syndrome are similar to those in classic HCM.

Entities:  

Mesh:

Year:  1996        PMID: 8992870     DOI: 10.1111/j.1442-200x.1996.tb03445.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  10 in total

1.  Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

Authors:  Talita M Marin; Kimberly Keith; Benjamin Davies; David A Conner; Prajna Guha; Demetrios Kalaitzidis; Xue Wu; Jessica Lauriol; Bo Wang; Michael Bauer; Roderick Bronson; Kleber G Franchini; Benjamin G Neel; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

Review 2.  The role of the protein tyrosine phosphatase SHP2 in cardiac development and disease.

Authors:  Jessica Lauriol; Fabrice Jaffré; Maria I Kontaridis
Journal:  Semin Cell Dev Biol       Date:  2014-09-22       Impact factor: 7.727

3.  Pulmonary interstitial glycogenosis associated with pulmonary hypertension and hypertrophic cardiomyopathy.

Authors:  Abdullah Alkhorayyef; Lindsay Ryerson; Alicia Chan; Ernest Phillipos; Atilano Lacson; Ian Adatia
Journal:  Pediatr Cardiol       Date:  2012-03-28       Impact factor: 1.655

4.  MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation.

Authors:  Xue Wu; Jeremy Simpson; Jenny H Hong; Kyoung-Han Kim; Nirusha K Thavarajah; Peter H Backx; Benjamin G Neel; Toshiyuki Araki
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

5.  Noonan syndrome in a premature infant with hypertrophic cardiomyopathy and death in infancy.

Authors:  William Gibson; Cynthia Trevenen; Michael Giuffre; Alexander K C Leung
Journal:  J Natl Med Assoc       Date:  2005-06       Impact factor: 1.798

6.  Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank.

Authors:  Kiran J Biddinger; Sean J Jurgens; Dimitri Maamari; Liam Gaziano; Seung Hoan Choi; Valerie N Morrill; Jennifer L Halford; Amit V Khera; Steven A Lubitz; Patrick T Ellinor; Krishna G Aragam
Journal:  JAMA Cardiol       Date:  2022-07-01       Impact factor: 30.154

7.  Low-dose dasatinib rescues cardiac function in Noonan syndrome.

Authors:  Jae-Sung Yi; Yan Huang; Andrea T Kwaczala; Ivana Y Kuo; Barbara E Ehrlich; Stuart G Campbell; Frank J Giordano; Anton M Bennett
Journal:  JCI Insight       Date:  2016-12-08

8.  Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal-regulated kinase/mitogen-activated protein kinase and RhoA signaling pathways.

Authors:  Maria I Kontaridis; Wentian Yang; Kendra K Bence; Darragh Cullen; Bo Wang; Natalya Bodyak; Qingen Ke; Aleksander Hinek; Peter M Kang; Ronglih Liao; Benjamin G Neel
Journal:  Circulation       Date:  2008-03-03       Impact factor: 29.690

Review 9.  Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes.

Authors:  Emanuele Monda; Marta Rubino; Michele Lioncino; Francesco Di Fraia; Roberta Pacileo; Federica Verrillo; Annapaola Cirillo; Martina Caiazza; Adelaide Fusco; Augusto Esposito; Fabio Fimiani; Giuseppe Palmiero; Giuseppe Pacileo; Paolo Calabrò; Maria Giovanna Russo; Giuseppe Limongelli
Journal:  Front Pediatr       Date:  2021-02-25       Impact factor: 3.569

10.  A Novel Noonan Syndrome RAF1 Mutation: Lethal Course in a Preterm Infant.

Authors:  Ana Ratola; Helena Moreira Silva; Ana Guedes; Céu Mota; Ana Cristina Braga; Dulce Oliveira; Artur Alegria; Carmen Carvalho; Sílvia Álvares; Elisa Proença
Journal:  Pediatr Rep       Date:  2015-06-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.